The aim of this study was to design a fusion protein construct, as an effective vaccine, consisting of PLAC1 (as a specific antigen) and Salmonella enterica fliC (as a bacterial adjuvant) that can stimulate humoral and cellular immune responses against breast cancer. This evidence concerns the gene PLAC1 and breast carcinoma.